thromboxanes has been researched along with Coronary Heart Disease in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 88 (80.00) | 18.7374 |
1990's | 20 (18.18) | 18.2507 |
2000's | 1 (0.91) | 29.6817 |
2010's | 1 (0.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, HJ; Ma, JW; Qiao, ZY; Xu, B | 1 |
Lecompte, T | 1 |
Kishi, Y; Maezawa, H; Nishiyama, K; Numano, F; Omori, K; Shimokado, K; Yajima, M | 1 |
Butt, RW; de Boer, AC; Genton, E; Johnston, RV; Turpie, AG | 1 |
Ito, T; Ogawa, K; Sakai, K; Satake, T; Watanabe, J | 1 |
Burke, SE; Lefer, AM; Lepran, I | 1 |
Jacobsen, DC | 1 |
Horalek, C; Mehta, J; Mehta, P | 1 |
Dollery, CT; Halushka, PV; MacDermot, J | 1 |
Inoue, T | 1 |
Abbate, R; Fortini, A; Gensini, GF; Masotti, G; Morettini, A; Neri Serneri, GG; Poggesi, L | 1 |
Gritsiuk, AI | 1 |
Cairns, J; Gyde, OH; Kuan, P; Reuben, SR | 1 |
Lewy, RI | 2 |
Liu, J | 1 |
Campbell, WB; Hillis, LD; Jackson, JA; Rehr, RB; Winniford, MD | 1 |
Abbate, R; Brunelli, C; Chierchia, S; Favilla, S; Gensini, GF; Mugnaini, C; Neri Serneri, GG; Parodi, O | 1 |
Fitscha, P; Kaliman, J; Peskar, BA; Sinzinger, H | 1 |
Coker, SJ; Parratt, JR | 3 |
Davidson, JF; Hutton, I; Rankin, AC; Tweddel, AC; Walker, ID | 1 |
Bailey, IA; Carey, F; Haworth, D; Smith, HJ | 1 |
Feldman, RL; Horalek, C; Mehta, J; Mehta, P | 1 |
de Boer, AC; Genton, E; Turpie, AG | 1 |
Ziemlański, S | 1 |
Hoshida, S; Kuzuya, T; Tada, M | 1 |
Coker, SJ; Ledingham, IM; Parratt, JR | 1 |
Campbell, WB; Dehmer, GJ; Firth, BG; Hillis, LD; Hirsh, PD; Willerson, JT | 1 |
Burch, JW; Ferraro, N; Hirshfeld, JW; Laskey, W; Martin, JL; Untereker, WJ; Wilson, JR | 1 |
Campbell, WB; Firth, BG; Hillis, LD; Hirsh, PD; Willerson, JT | 2 |
Hayashi, Y; Itoh, R; Kosuzume, H; Ohnishi, H; Suzuki, Y; Yamaguchi, K | 1 |
Coker, SJ; Ledingham, IM; Parratt, JR; Zeitlin, IJ | 2 |
Chen, LS; Ito, T; Ogawa, K; Satake, T | 1 |
Mehta, J; Mehta, P | 1 |
Feldman, RL; Mehta, J; Mehta, P | 1 |
Buckley, MJ; Kong, DL; Kono, K; Levine, FH; Peterson, MB; Philbin, DM; Watkins, WD | 1 |
Castaldi, PA | 1 |
Abbate, R; Gensini, GF; Masotti, G; Neri Serneri, GG; Poggesi, L | 1 |
Abbate, R; Gensini, GF; Laureano, R; Masotti, G; Neri Serneri, GG; Poggesi, L | 1 |
Verdecchia, P | 1 |
Addonizio, VP; Feldman, P; Fisher, CA; Harken, AH; Strauss, JF; Wetstein, L | 1 |
Hellstrom, HR | 2 |
Fujiwara, S; Goto, N; Hirata, M; Nishikawa, K; Shimamoto, N; Tanabe, M; Terashita, ZI | 1 |
Chierchia, S; Crea, F; de Caterina, R; Maseri, A; Patrono, C | 1 |
Butkus, A; Schumacher, OP; Shirey, EK | 1 |
Lefer, AM; Smith, EF | 1 |
Aharony, D; Claremon, D; Lefer, AM; Magolda, RL; Nicolaou, KC; Smith, EF; Smith, JB | 1 |
Abe, H; Inoue, M; Inui, M; Kodama, K; Kuzuya, T; Mishima, M; Tada, M; Yamada, M | 1 |
Bickerton, M; Lefer, AM; Magolda, R; Nicolaou, KC; Schrör, K; Smith, EF; Smith, JB | 1 |
Lefer, AM; Lewy, RI; Silver, MJ; Smith, JB; Walinsky, P; Wiener, L | 1 |
Lefer, AM; Smith, EF; Smith, JB | 1 |
Abe, H; Fukushima, M; Inoue, M; Kodama, K; Kuzuya, T; Tada, M | 1 |
Brooks, LA; Dellsperger, KC; Eller, BT | 1 |
Henzen, C | 1 |
Whitehead, M | 1 |
Bischoff, P; Eisenmann, B; Epailly, E; Geny, B; Haberey, P; Mettauer, B; Muan, B; Piquard, F | 1 |
Oian, P; Osterud, B | 1 |
Förster, W; Parratt, JR | 1 |
Barnette, WE; Gasic, GP; Lefer, AM; Nicolaou, KC; Ogletree, ML; Silver, MJ; Smith, JB | 1 |
Fuccella, LM | 1 |
Kobayashi, M; Morooka, S; Sakamoto, M; Shimamoto, T; Takahashi, T; Takashima, Y | 1 |
Horrobin, DF; Karmazyn, M; Manku, MS | 1 |
Kelman, BJ; Schneider, MD | 1 |
Grodzińska, L; Gryglewski, RJ; Marcinkiewicz, E; Musiał, J; Serwońska, M; Szczeklik, A | 1 |
Lewy, RI; Saia, J; Silver, MJ; Smith, JB; Walinsky, P; Wiener, L | 1 |
Kobayashi, M; Morooka, S; Shimamoto, T | 1 |
Chi, LG; Kitzen, JM; Lucchesi, BR; Uprichard, AC | 1 |
Beisiegel, B; Darius, H; Erbel, R; Hafner, G; Meyer, J; Pop, T; Rupprecht, HJ; Treese, N | 1 |
Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M | 1 |
Bass, TA; Bove, AA; Cowley, M; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, AS; Vetrovec, G; Whitworth, HB | 1 |
Kolthay, E; Makáry, A; Mihai, K; Petó, J | 1 |
Force, T; Hibberd, P; Leaf, A; Lorenz, R; Milani, R; Uedelhoven, W; Weber, P | 1 |
Botting, RM; Vane, JR | 1 |
Kramer, J; Makary, A; Mihai, K; Peto, J; Szamosi, T | 1 |
Fehér, G; Seres, T; Takács, EI | 1 |
Engler, RL; Ito, BR; Roth, DM | 1 |
Fiedler, VB; Perzborn, E; Seuter, F | 1 |
Ermakovich, II; Ladnyĭ, AI; Tseluĭko, VI; Volkov, VI | 1 |
Mehta, JL; Nichols, WW | 1 |
Bleifeld, W; Hamm, CW; Lorenz, RL; Riesner, H; Weber, PC | 1 |
Chenoweth, DE; Engler, RL; Ito, BR; Lefer, AM; Roth, DM | 1 |
Lefer, AM | 1 |
Buja, LM; Campbell, WB; Eidt, J; Golino, P; Willerson, JT | 1 |
Maseri, A | 1 |
Bhat, AM; Lefer, AM; Osborne, JA; Sacks, H | 1 |
Frishman, WH; Miller, KP | 1 |
Lefer, AM; Osborne, JA | 1 |
Ney, P; Schrör, K; Thiemermann, C | 1 |
Hosaka, T; Namba, K; Nomura, S; Numano, F; Sekine, M; Yajima, M | 1 |
Coker, SJ; Parratt, JR; Wainwright, CL; Zeitlin, IJ | 1 |
Parratt, JR; Wainwright, CL | 1 |
de Gaetano, G; Dejana, E; Del Maschio, A; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F | 1 |
Peskar, BA; Simmet, T | 1 |
Ashton, JH; Buja, LM; Campbell, WB; Fitzgerald, C; Ogletree, ML; Raheja, S; Schmitz, JM; Taylor, AL; Willerson, JT | 1 |
Lecompte, T; Samama, M | 1 |
Buja, LM; Hillis, LD; Willerson, JT; Winniford, M | 1 |
Castagnoli, MN; De Gaetano, G; Dejana, E; Del Maschio, A; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M | 1 |
Gay, WA; Subramanian, VA; Tack-Goldman, K; Weksler, BB | 1 |
Hirose, H; Kaneko, M; Kawashima, Y; Kuzuya, T; Matsuda, H; Nakano, S; Nomura, F; Ohtani, M; Sasako, Y; Shirakura, R | 1 |
Ito, T; Ogawa, K | 1 |
Couquelet, J; Dossou-Gbete, V; Lasserre, B; Palhares de Miranda, AL; Pham, HC; Tronche, P | 1 |
Angoli, L; Bramucci, E; Cafiso, A; De Servi, S; Falcone, C; Ferrario, M; Gavazzi, A; Ghio, S; Mussini, A; Vidale, E | 1 |
18 review(s) available for thromboxanes and Coronary Heart Disease
Article | Year |
---|---|
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine | 2002 |
Prostaglandins and cardiovascular disease--a review.
Topics: Arachidonic Acids; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Epoprostenol; Extracorporeal Circulation; Fetus; Homeostasis; Humans; Prostaglandin Antagonists; Prostaglandins; Pulmonary Embolism; Shock; Thromboxanes | 1983 |
Thromboxane and prostacyclin in disease: a review.
Topics: Animals; Coronary Disease; Diabetes Mellitus; Epoprostenol; Humans; Hydronephrosis; Male; Platelet Aggregation; Shock; Thromboxane A2; Thromboxanes; Vasoconstriction | 1983 |
Platelet consumption in cardiovascular disease.
Topics: Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cardiovascular Diseases; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Heart Valve Diseases; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Rabbits; Radionuclide Imaging; Thromboembolism; Thrombosis; Thromboxanes | 1982 |
[Physiological role of dietary fats with special reference to nonesterified fatty acids].
Topics: Adolescent; Adult; Aged; Animals; Arteriosclerosis; Child; Child, Preschool; Coronary Disease; Dietary Fats; Energy Intake; Fatty Acids, Nonesterified; Female; Humans; Infant; Lipid Metabolism; Male; Middle Aged; Nutritional Requirements; Prostaglandins; Thromboxanes | 1982 |
[Interrelationships between the hemostatic system and the prostaglandin system in the pathogenesis of ischemic cardiopathy].
Topics: Angina Pectoris; Blood Coagulation Disorders; Blood Platelet Disorders; Coronary Disease; Coronary Vasospasm; Fibrinopeptide A; Humans; Myocardial Infarction; Prostaglandins; Thromboxanes | 1981 |
Prostaglandins in ischemic heart disease.
Topics: Blood Platelets; Coronary Disease; Epoprostenol; Humans; Prostaglandins; Sympathetic Nervous System; Thromboxanes | 1982 |
[Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Platelet Count; Prostaglandins; Sulfinpyrazone; Thromboxanes | 1982 |
Progestins and androgens.
Topics: Androgens; Blood Coagulation; Blood Flow Velocity; Blood Vessels; Carbohydrate Metabolism; Coronary Disease; Estrogen Replacement Therapy; Female; Fibrinolysis; Humans; Lipid Metabolism; Lipoproteins; Postmenopause; Progestins; Prostaglandins; Risk Factors; Thromboxanes | 1994 |
Monocyte-platelet function and protection against cardiovascular disease.
Topics: Adult; Aged; Blood Platelets; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Monocytes; Thromboplastin; Thromboxanes; Tumor Necrosis Factor-alpha | 1996 |
The case of low-dose aspirin for the prevention of myocardial infarction: but how low is low?
Topics: Aspirin; Coronary Disease; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Thromboxanes | 1997 |
Clinical pharmacology of inhibitors of platelet aggregation.
Topics: Bleeding Time; Blood Coagulation Disorders; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Dose-Response Relationship, Drug; Epoprostenol; Humans; In Vitro Techniques; Ischemia; Platelet Aggregation; Thrombophlebitis; Thromboxanes | 1979 |
The potential role of thromboxane inhibitors in preventing myocardial ischaemic injury.
Topics: Coronary Disease; Humans; Thromboxane A2; Thromboxanes | 1990 |
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
Topics: Angina Pectoris; Animals; Biomechanical Phenomena; Blood Platelets; Coronary Circulation; Coronary Disease; Coronary Vessels; Humans; Muscle Tonus; Platelet Aggregation; Thrombosis; Thromboxanes | 1989 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
Eicosanoids and cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Prostaglandins; Thromboxanes | 1988 |
Eicosanoids and the coronary circulation.
Topics: Anaphylaxis; Animals; Coronary Circulation; Coronary Disease; Epoprostenol; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Platelet Activating Factor; Thromboxanes | 1986 |
[Analogs of prostaglandin-related substances and inhibitors of their synthesis and metabolism. Clinical application: cardiovascular diseases].
Topics: Angina Pectoris; Aspirin; Coronary Disease; Epoprostenol; Humans; Hypertension; Methacrylates; Myocardial Infarction; Oxidoreductases; Platelet Aggregation; Thromboxane-A Synthase; Thromboxanes; Urokinase-Type Plasminogen Activator | 1985 |
8 trial(s) available for thromboxanes and Coronary Heart Disease
Article | Year |
---|---|
n-3 polyunsaturated fatty acids and ischemic heart disease.
Topics: Adult; Animals; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Male; Rats; Thromboxanes | 1982 |
Effects of dazoxiben on exercise performance in chronic stable angina.
Topics: Angina Pectoris; Coronary Disease; Double-Blind Method; Humans; Imidazoles; Nitroglycerin; Oxidoreductases; Physical Exertion; Platelet Aggregation; Thrombelastography; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1983 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
Topics: Albumins; Animals; Anti-Inflammatory Agents; Blood Gas Analysis; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Disease; Diastole; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echocardiography; Exercise Test; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, Intravenous; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Pulmonary Circulation; Swine; Systole; Thromboxanes | 1993 |
[Modification of thrombocyte function in diagnostic and therapeutic interventions in cardiology].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Fibrinolysis; Follow-Up Studies; Humans; Molsidomine; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Thromboxanes; Tissue Plasminogen Activator | 1991 |
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Mid-Atlantic Region; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Prostaglandin; Receptors, Thromboxane; Recurrence; Sulfonamides; Thromboxanes | 1991 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Hemorrhage; Humans; Myocardial Revascularization; Prospective Studies; Sulfinpyrazone; Thromboxanes | 1986 |
85 other study(ies) available for thromboxanes and Coronary Heart Disease
Article | Year |
---|---|
Study of molecular mechanism of Prostaglandin E1 in inhibiting coronary heart disease.
Topics: Alprostadil; Animals; Caspase 3; Cholesterol, Dietary; Cholesterol, LDL; Coronary Disease; Estradiol; fas Receptor; Female; Fibroblast Growth Factor 2; Luteinizing Hormone; Myocardium; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Thromboxanes; Triglycerides; Vascular Endothelial Growth Factor A | 2013 |
Plasma thromboxane B2 levels and atherosclerotic disorders.
Topics: Adolescent; Adult; Arteriosclerosis; Arteriosclerosis Obliterans; Child; Chromatography, Gel; Circadian Rhythm; Coronary Disease; Diabetes Mellitus; Dinoprost; Female; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Prostaglandins F; Takayasu Arteritis; Thromboangiitis Obliterans; Thromboxane B2; Thromboxanes | 1981 |
Platelet release and thromboxane synthesis in symptomatic coronary artery disease.
Topics: Aged; beta-Thromboglobulin; Blood Platelets; Coronary Disease; Female; Humans; Male; Middle Aged; Thromboxane B2; Thromboxanes | 1982 |
Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
Topics: 6-Ketoprostaglandin F1 alpha; Acrylates; Animals; Coronary Circulation; Coronary Disease; Dogs; Heart; Indomethacin; Kinetics; Lactates; Lactic Acid; Methacrylates; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes | 1983 |
Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids.
Topics: Animals; Cats; Coronary Disease; Creatine Kinase; Dibenzothiepins; Electrocardiography; In Vitro Techniques; Male; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes; Vasoconstriction | 1984 |
The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Blood Platelets; Blood Pressure; Blood Vessels; Coronary Disease; Epoprostenol; Heart Rate; Humans; Middle Aged; Physical Exertion; Prostaglandins; Thromboxane A2; Thromboxanes | 1983 |
[Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
Topics: Aged; Aspirin; Blood Platelets; Cerebral Infarction; Coronary Disease; Dipyridamole; Epoprostenol; Fatty Acids; Female; Humans; Male; Middle Aged; Phospholipids; Thromboxane A2; Thromboxanes; Trapidil | 1983 |
Role of prostacyclin and thromboxane A2 in ischaemic heart disease.
Topics: Blood Platelets; Coronary Disease; Epoprostenol; Humans; Sympathetic Nervous System; Thromboxane A2; Thromboxanes | 1984 |
[Problems of intravascular blood coagulation and thrombus formation in ischemic heart disease].
Topics: Blood Coagulation; Coronary Disease; Disseminated Intravascular Coagulation; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis; Thromboxanes | 1984 |
Role of thromboxanes in vasotonic versus vaso-occlusive angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cardiac Pacing, Artificial; Coronary Disease; Coronary Vasospasm; Heparin; Humans; Lactates; Thromboxane B2; Thromboxanes | 1983 |
[Effect of Paeonia obovata 801 on metabolism of thromboxane B2 and arachidonic acid and on platelet aggregation in patients with coronary heart disease and cerebral thrombosis].
Topics: Aged; Arachidonic Acids; Blood Platelets; China; Coronary Disease; Female; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Plant Extracts; Plants, Medicinal; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1983 |
Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations.
Topics: Adult; Aged; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Humans; Male; Middle Aged; Nitroglycerin; Thromboxane A2; Thromboxane B2; Thromboxanes; Vasodilation | 1984 |
Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations.
Topics: beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Hemostasis; Humans; Male; Middle Aged; Platelet Aggregation; Risk; Thromboxane A2; Thromboxanes | 1981 |
Follow-up of in-vivo platelet function (platelet half-life, thromboxane B2) in patients with coronary heart disease.
Topics: Adult; Aged; Blood Platelets; Coronary Disease; Female; Follow-Up Studies; Half-Life; Humans; Male; Middle Aged; Platelet Function Tests; Thromboxane B2; Thromboxanes | 1984 |
The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arrhythmias, Cardiac; Blood Gas Analysis; Blood Pressure; Coronary Disease; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; Male; Perfusion; Thromboxane B2; Thromboxanes; Timolol | 1984 |
Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Hemodynamics; Humans; Imidazoles; Middle Aged; Myocardium; Oxidoreductases; Platelet Aggregation; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1983 |
Effects of vascular trauma and transient myocardial ischaemia on coronary venous prostaglandin levels in the dog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Catheterization; Coronary Disease; Coronary Vessels; Dogs; Female; Indomethacin; Male; Thromboxane B2; Thromboxanes | 1983 |
Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina.
Topics: Adult; Aged; Angina Pectoris; Aorta; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Disease; Coronary Vessels; Humans; Male; Middle Aged; Prostaglandins; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
[Prostanoids and coronary circulation].
Topics: Coronary Circulation; Coronary Disease; Epoprostenol; Humans; Prostaglandins; Thromboxane A2; Thromboxanes | 1982 |
The chief scientist reports... prostaglandins, thromboxanes and the early events of myocardial ischaemia.
Topics: Arachidonic Acids; Coronary Disease; Humans; Myocardium; Prostaglandins; Thromboxanes | 1983 |
Effects of provocation on transcardiac thromboxane in patients with coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Aorta; Cardiac Pacing, Artificial; Cold Temperature; Coronary Disease; Coronary Vessels; Electrocardiography; Female; Humans; Isometric Contraction; Male; Middle Aged; Pain; Thromboxane B2; Thromboxanes | 1983 |
Effect of atrial pacing on intracoronary thromboxane production in coronary artery disease.
Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Disease; Female; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Middle Aged; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Female; Humans; Lactates; Male; Middle Aged; Prostaglandins; Prostaglandins E; Prostaglandins F; Thromboxane B2; Thromboxanes | 1981 |
Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Cholesterol; Coronary Disease; Lipoproteins, HDL; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandins F; Pyrimidines; Rabbits; Rats; Thromboxane A2; Thromboxane B2; Thromboxanes; Trapidil | 1981 |
Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Disease; Coronary Vessels; Disease Models, Animal; Dogs; Heart; Prostaglandins F; Thromboxane B2; Thromboxanes | 1981 |
Changes of plasma 6-keto-PGF1 alpha and thromboxane B2 levels and platelet aggregation after tourniquet ischemia on the upper limb in normal subjects and patients with ischemic heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arm; Blood Circulation; Coronary Disease; Female; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation; Thromboxane B2; Thromboxanes; Tourniquets | 1982 |
Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Topics: Arteriosclerosis; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Humans; Platelet Aggregation; Propranolol; Tachycardia; Thromboxane B2; Thromboxanes | 1981 |
Severe intracoronary thromboxane release preceding acute coronary artery occlusion.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Coronary Disease; Humans; Male; Platelet Count; Prostaglandins; Radiography; Thromboxane B2; Thromboxanes | 1982 |
Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
Topics: 6-Ketoprostaglandin F1 alpha; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Hematocrit; Humans; Platelet Count; Thromboxane A2; Thromboxane B2; Thromboxanes | 1982 |
Mediation of cardiac ischemia by thromboxanes released from human platelets.
Topics: Aspirin; Blood Platelets; Coronary Circulation; Coronary Disease; Epoprostenol; Fluorescence; Humans; Photography; Prostaglandins E; Thrombin; Thromboxanes | 1982 |
The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic disease. Resistance vessel-spasm hypothesis of ischemic disease.
Topics: Animals; Blood Platelets; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Coronary Vessels; Hemostasis; Homeostasis; Humans; Myocardial Infarction; Prostaglandin Antagonists; Prostaglandins; Thromboxanes; Vascular Resistance; Vasoconstriction; Vasodilation | 1982 |
Coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion in anaesthetised dogs.
Topics: Animals; Biological Assay; Blood Pressure; Catecholamines; Coronary Circulation; Coronary Disease; Dogs; Female; Heart Rate; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Perfusion; Rabbits; Thromboxane A2; Thromboxane B2; Thromboxanes | 1982 |
Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease.
Topics: Adult; Aged; Aorta; Arteries; Blood Chemical Analysis; Blood Specimen Collection; Catheterization; Coronary Disease; Female; Humans; Male; Methods; Middle Aged; Radioimmunoassay; Thromboxane A2; Thromboxane B2; Thromboxanes | 1982 |
Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina.
Topics: Adult; Aspirin; Coronary Disease; Coronary Vasospasm; Electrocardiography; Humans; Male; Middle Aged; Thromboxane A2; Thromboxane B2; Thromboxanes | 1982 |
Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
Topics: Blood Platelets; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Humans; Lipids; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1982 |
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen.
Topics: Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Cats; Cell Membrane; Coronary Disease; Creatine Kinase; Lysosomes; Male; Naproxen; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1981 |
Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog.
Topics: Animals; Blood Pressure; Cardiac Output; Cathepsin D; Cathepsins; Cats; Coronary Disease; Coronary Vessels; Creatine Kinase; Heart Rate; Male; Regional Blood Flow; Thromboxane A2; Thromboxanes; Vasoconstrictor Agents | 1981 |
Thromboxane in ischemic heart disease.
Topics: Coronary Disease; Humans; Thromboxanes | 1981 |
Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Coronary Disease; Dogs; Myocardium; Thromboxane B2; Thromboxanes | 1981 |
Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Female; Humans; Male; Middle Aged; Thromboxane B2; Thromboxanes | 1981 |
Preservation of ischemic myocardium by pinane thromboxane A2.
Topics: Animals; Blood Pressure; Cathepsins; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Heart; Heart Rate; Male; Thromboxane A2; Thromboxane B2; Thromboxanes | 1980 |
Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Brachial Artery; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Heart Rate; Humans; Lactates; Male; Middle Aged; Radioimmunoassay; Thromboxane B2; Thromboxanes; Time Factors; Vasoconstrictor Agents | 1980 |
Effect of elevated plasma-free fatty acids on thromboxane release in patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Angiocardiography; Coronary Disease; Fatty Acids, Nonesterified; Female; Heparin; Humans; Male; Middle Aged; Prostaglandins; Thromboxane B2; Thromboxanes | 1980 |
Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.
Topics: Animals; Arachidonic Acids; Cats; Coronary Disease; Creatine Kinase; Imidazoles; In Vitro Techniques; Liver; Lysosomes; Male; Myocardial Contraction; Myocardium; Thromboxane A2; Thromboxane B2; Thromboxanes | 1980 |
Thromboxane A2 release and the injury-spasm hypothesis.
Topics: Coronary Disease; Coronary Vessels; Humans; Spasm; Thromboxane A2; Thromboxanes | 1980 |
Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
Topics: Angina Pectoris; Angina Pectoris, Variant; Cardiac Pacing, Artificial; Coronary Disease; Humans; Male; Radioimmunoassay; Thromboxane A2; Thromboxane B2; Thromboxanes | 1980 |
Thromboxane contributes to submaximal coronary dilation during myocardial ischemia.
Topics: Animals; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Fatty Acids, Unsaturated; Female; Hemodynamics; Hydrazines; Male; Microcirculation; Muscle Tonus; Thromboxanes; Vasodilation; Video Recording | 1995 |
[Fish oil--healing principle in the Eskimo diet?].
Topics: Arteriosclerosis; Coronary Disease; Dietary Fats; Fatty Acids, Omega-3; Fish Oils; Humans; Inuit; Prostaglandins; Thromboxanes | 1995 |
Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.
Topics: Animals; Blood Pressure; Cats; Coronary Circulation; Coronary Disease; Epoprostenol; Heart Rate; Hemodynamics; In Vitro Techniques; Lysosomes; Myocardial Contraction; Platelet Aggregation; Prostaglandins; Thromboxanes; Vascular Resistance | 1978 |
Experimental ischemic heart disease--effects of synthetic thromboxane A2.
Topics: Animals; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; Hypotension; Myocardium; Necrosis; Phthalazines; Prostaglandins H; Rabbits; Thromboxane A2; Thromboxanes | 1979 |
The mechanism of coronary artery spasm: roles of oxygen, prostaglandins, sex hormones and smoking.
Topics: Coronary Circulation; Coronary Disease; Estradiol; Female; Humans; Hypoxia; Progesterone; Prostaglandins; Smoking; Testosterone; Thromboxane A2; Thromboxanes | 1979 |
A proposed mechanism(s) of transitory ischemic injury to myocardium.
Topics: Animals; Blood Platelets; Blood Pressure; Collagen; Connective Tissue; Coronary Circulation; Coronary Disease; Electrocardiography; Guinea Pigs; Heart Ventricles; Ischemia; Lung; Platelet Aggregation; Prostaglandins; Thromboxanes | 1979 |
Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
Topics: Adult; Arachidonic Acids; Aspirin; Blood Platelets; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Malonates; Malondialdehyde; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1979 |
Does eicosapentenoic acid prevent thrombosis and atherosclerosis?
Topics: Arteriosclerosis; Coronary Disease; Humans; Thromboxanes | 1979 |
Comparison of plasma concentrations of thromboxane B2 in Prinzmetal's variant angina and classical angina pectoris.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Female; Humans; Male; Middle Aged; Radioimmunoassay; Rest; Thromboxane B2; Thromboxanes | 1979 |
Experimental ischemic heart disease induced by thromboxane A2 in rabbits.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; Heart Ventricles; Myocardium; Necrosis; Rabbits; Thromboxane A2; Thromboxanes | 1977 |
Effects of combined thromboxane synthetase inhibition/thromboxane receptor antagonism in two models of sudden cardiac death in the canine: limited role for thromboxane.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Arrhythmias, Cardiac; Collagen; Coronary Disease; Death, Sudden; Disease Models, Animal; Dogs; Electric Stimulation; Electrophysiology; Female; Heart Rate; Male; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1990 |
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine | 1991 |
Prostacyclin and thromboxane levels of children of parents suffering from early ischemic heart disease.
Topics: Adolescent; Child; Child, Preschool; Coronary Disease; Epoprostenol; Humans; Thromboxanes; Time Factors | 1991 |
Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile.
Topics: Aged; Arachidonic Acid; Aspirin; Coronary Disease; Eicosanoids; Eicosapentaenoic Acid; Epoprostenol; Female; Fish Oils; Humans; Male; Middle Aged; Phospholipids; Prostaglandin Endoperoxides; Thromboxanes | 1991 |
Heart disease, aspirin, and fish oil.
Topics: Aspirin; Coronary Disease; Epoprostenol; Fatty Acids; Fish Oils; Humans; Thromboxanes | 1991 |
Potential markers of the atherosclerotic process in high-risk children.
Topics: Adolescent; Arteriosclerosis; Biomarkers; Child; Child, Preschool; Cholesterol; Cholesterol, LDL; Complement C3; Coronary Disease; Epoprostenol; Female; Humans; Lipid Peroxides; Lipoproteins, HDL; Male; Phenotype; Risk Factors; Thromboxanes; Triglycerides | 1991 |
Role of biochemical changes in the development of early ischemic and reperfusion arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Epoprostenol; Free Radicals; Myocardial Reperfusion Injury; Myocardium; Thromboxanes | 1990 |
Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs.
Topics: Animals; Complement C5a; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Injections, Intra-Arterial; Leukotrienes; Male; Myocardial Contraction; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Thromboxane; SRS-A; Swine; Thromboxane A2; Thromboxanes; Time Factors | 1990 |
Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbazoles; Coronary Disease; Coronary Vessels; Disease Models, Animal; Dogs; Hemodynamics; Myocardial Infarction; Prostaglandin Endoperoxides, Synthetic; Sulfonamides; Swine; Thromboxanes; Vasoconstriction | 1990 |
[The prostacyclin-thromboxane system and the functional properties of the thrombocytes in patients of different ages with ischemic heart disease].
Topics: Adult; Aging; Angina Pectoris; Blood Platelets; Coronary Disease; Epoprostenol; Exercise Test; Humans; Male; Middle Aged; Physical Exertion; Thromboxanes | 1990 |
A prospective study of the diagnostic value of urinary thromboxane in patients presenting with acute chest pain.
Topics: Aged; Angina Pectoris; Angiography; Coronary Disease; Diagnosis, Differential; Emergencies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Prospective Studies; Thromboxanes | 1990 |
Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arrhythmias, Cardiac; Coronary Disease; Dogs; Epoprostenol; Iloprost; Norepinephrine; Perfusion; Pyrazoles; Pyrazolones; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes | 1985 |
Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Complement C5a; Coronary Disease; Coronary Vessels; Cyclooxygenase Inhibitors; Female; Indomethacin; Injections, Intra-Arterial; Leukocyte Count; Leukocytes; Male; Myocardium; Prostaglandin Endoperoxides, Synthetic; Swine; Thromboxane B2; Thromboxanes | 1989 |
Role of thromboxane A2 in myocardial ischemia and circulatory shock.
Topics: Animals; Cats; Coronary Disease; Myocardial Reperfusion Injury; Phenylacetates; Platelet Aggregation; Rabbits; Shock; Sulfonamides; Thromboxane A2; Thromboxanes | 1989 |
[Neurohumoral mechanisms in the physiopathology of coronary occlusion].
Topics: Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Coronary Vasospasm; Embolism; Epoprostenol; Humans; Neurotransmitter Agents; Plasminogen Activators; Platelet Aggregation; Thromboxanes; Vasoconstriction | 1985 |
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Topics: Acute Disease; Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Heart Rate; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Phenylacetates; Sulfonamides; Thromboxanes | 1989 |
Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Coronary Disease; Coronary Vessels; Creatine Kinase; Male; Phenylacetates; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Reference Values; Sulfonamides; Thromboxanes | 1988 |
The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
Topics: Adenosine Triphosphate; Animals; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Female; Heart Rate; Hemodynamics; Leukocytosis; Male; Myocardial Contraction; Myocardium; Neutrophils; Oxygen; Phenylacetates; Platelet Count; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes | 1988 |
Plasma thromboxane B2, 6-keto PGF1 alpha and cyclic nucleotides levels as related to treadmill exercise test in patients with ischemic heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Coronary Disease; Cyclic AMP; Cyclic GMP; Exercise Test; Female; Humans; Male; Middle Aged; Physical Exertion; Thromboxane B2; Thromboxanes | 1985 |
Antiarrhythmic effects of the thromboxane antagonist BM 13.177.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbon Dioxide; Coronary Disease; Dogs; Hemodynamics; Oxygen; Sulfonamides; Thromboxanes | 1987 |
Prostacyclin and thromboxane levels during cardiac ischemia in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Circulation; Coronary Disease; Dogs; Epoprostenol; Lactates; Lactic Acid; Regional Blood Flow; Thromboxane B2; Thromboxanes | 1985 |
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Epoprostenol; Hemodynamics; Male; Microscopy, Electron, Scanning; Prostaglandin Endoperoxides, Synthetic; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2; Thromboxanes | 1986 |
Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes.
Topics: Angina, Unstable; Animals; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Dogs; Humans; Platelet Aggregation; Prostaglandins; Serotonin; Syndrome; Thromboxanes | 1986 |
Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arteries; Constriction, Pathologic; Coronary Circulation; Coronary Disease; Dogs; Ligation; Male; Thromboxane B2; Thromboxanes | 1985 |
AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Biphenyl Compounds; Coronary Disease; Dogs; Female; Hemodynamics; Male; Oxygen; Perfusion; Prostaglandins; Thromboxanes | 1985 |
Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Blood Platelets; Blood Vessels; Coronary Disease; Epoprostenol; Humans; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1985 |
[Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
Topics: Animals; Coronary Disease; Dogs; Epoprostenol; In Vitro Techniques; Kinetics; Perfusion; Thromboxane A2; Thromboxanes | 1985 |
Enhanced prostacyclin biosynthesis and decreased thromboxane formation by 3-dimethylamino 5-(2',6'-dichlorobenzylidene) 6-methyl (4H)-pyridazine (PC 89).
Topics: Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Coronary Disease; Epoprostenol; Horses; In Vitro Techniques; Kinetics; Microsomes; Pyridazines; Thromboxane A2; Thromboxanes | 1985 |
[Myocardial ischemia during exertion. Correlations between blood levels of thromboxane B2 and changes in coronary flow and resistance].
Topics: Adult; Coronary Circulation; Coronary Disease; Female; Humans; Male; Middle Aged; Physical Exertion; Thromboxane B2; Thromboxanes; Vascular Resistance | 1985 |